Evidence map›Paper›PMID 39160256›Full record

ArticleScientific reports2024

Germ aversion is a risk factor for chronic low back pain and shoulder pain under the COVID-19 pandemic: an internet-based panel study.

Yuki Mashima, Morihiko Kawate, Yihuan Wu, Yuta Shinohara, Reiko Hoshino, Saki Takaoka, Chisato Tanaka, Masahito Tokita, Akihito Shimazu, Kenta Wakaizumi

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuki MashimaInterdisciplinary Pain Center, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.
Morihiko KawateInterdisciplinary Pain Center, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.
Yihuan WuInterdisciplinary Pain Center, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.
Yuta ShinoharaInterdisciplinary Pain Center, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.
Reiko HoshinoInterdisciplinary Pain Center, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.
Saki TakaokaInterdisciplinary Pain Center, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.
Chisato TanakaInterdisciplinary Pain Center, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.
Masahito TokitaKeio Research Institute at SFC, Keio University, Fujisawa, Kanagawa, Japan.
Akihito ShimazuFaculty of Policy Management, Keio University, Fujisawa, Kanagawa, Japan.
Kenta WakaizumiInterdisciplinary Pain Center, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. kwaka@keio.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has increased germ aversion, an aversive affective response to a high likelihood of pathogen transmission. While psychological factors are associated with chronic pain, the relationship between germ aversion and chronic pain remains unexplored. This study aimed to examine the relationship between germ aversion and new-onset and prognosis of chronic pain using longitudinal data collected during the COVID-19 pandemic. We conducted web-based surveys of full-time workers at baseline and after three months. Data were collected on demographic characteristics, psychological factors, and chronic pain. Germ aversion was assessed using a modified Perceived Vulnerability to Disease scale. We analyzed responses from 1265 panelists who completed the survey twice. The prevalence of chronic low back pain (CLBP) and chronic neck and shoulder pain (CNSP) was associated with sex, short sleep duration, psychological distress, loneliness, and germ aversion. Stratified analyses showed that germ aversion was a risk factor for CLBP at three months in both individuals with and without CLBP at baseline, and for CNSP at three months in those with CNSP at baseline, even after adjustment for confounders. In conclusion, this preliminary study suggests that high germ aversion is a risk factor for CLBP and CNSP in young and middle-aged workers.

Indexed as

COVID-19Low Back PainShoulder PainAdultChronic PainFemaleHumansInternetLongitudinal StudiesMaleMiddle AgedPandemicsPrevalenceRisk FactorsSARS-CoV-2Surveys and QuestionnairesBehavior immune systemChronic musculoskeletal painChronic painCoronavirus disease 2019 (COVID-19)Fear for infectionGerm aversion

Identifiers

PMID39160256
PMCPMC11333631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.